Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report

The REMAP-CAP Investigators, View ORCID ProfileAnthony C. Gordon, Paul R. Mouncey, Farah Al-Beidh, Kathryn M. Rowan, Alistair D. Nichol, Yaseen M. Arabi, Djillali Annane, Abi Beane, Wilma van Bentum-Puijk, Lindsay R. Berry, Zahra Bhimani, Marc J.M. Bonten, Charlotte A. Bradbury, Frank M. Brunkhorst, Adrian Buzgau, Allen C. Cheng, Michelle A. Detry, Eamon J. Duffy, Lise J. Estcourt, Mark Fitzgerald, Herman Goossens, Rashan Haniffa, Alisa M. Higgins, Thomas E. Hills, Christopher M. Horvat, Francois Lamontagne, Patrick R. Lawler, Helen L. Leavis, Kelsey M. Linstrum, Edward Litton, Elizabeth Lorenzi, John C. Marshall, Florian B. Mayr, Danny McAuley, Anna McGlothlin, Shay P McGuinness, Bryan J. McVerry, Stephanie K. Montgomery, Susan C. Morpeth, Srinivas Murthy, Katrina Orr, Rachael L. Parke, Jane C. Parker, Asad E. Patanwala, Ville Pettilä, Emma Rademaker, Marlene S. Santos, Christina T. Saunders, Christopher W. Seymour, Manu Shankar-Hari, Wendy I. Sligl, Alexis F. Turgeon, Anne M. Turner, Frank L. van de Veerdonk, Ryan Zarychanski, Cameron Green, Roger J. Lewis, Derek C. Angus, Colin J. McArthur, Scott Berry, Steve A. Webb, Lennie P.G. Derde
doi: https://doi.org/10.1101/2021.01.07.21249390
1Imperial College London, London, United Kingdom
Anthony C. Gordon
1Imperial College London, London, United Kingdom
2Imperial College Healthcare NHS Trust, St. Mary’s Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anthony C. Gordon
  • For correspondence: anthony.gordon@imperial.ac.uk
Paul R. Mouncey
3Intensive Care National Audit & Research Centre (ICNARC), London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farah Al-Beidh
1Imperial College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn M. Rowan
3Intensive Care National Audit & Research Centre (ICNARC), London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alistair D. Nichol
4Monash University, Melbourne, Australia
5University College Dublin, Dublin, Ireland
6Alfred Health, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yaseen M. Arabi
7King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Djillali Annane
8Hospital Raymond Poincaré (Assistance Publique Hôpitaux de Paris), Garches, France
9Université Versailles SQY - Université Paris Saclay, Montigny-le-Bretonneux, France
10Université Paris Saclay - UVSQ – INSERM, Garches, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abi Beane
11University of Oxford, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wilma van Bentum-Puijk
12University Medical Center Utrecht, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lindsay R. Berry
13Berry Consultants, Austin, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zahra Bhimani
14St. Michael’s Hospital Unity Health, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc J.M. Bonten
12University Medical Center Utrecht, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotte A. Bradbury
15University of Bristol, Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank M. Brunkhorst
16Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian Buzgau
4Monash University, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allen C. Cheng
4Monash University, Melbourne, Australia
17Alfred Health, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle A. Detry
13Berry Consultants, Austin, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eamon J. Duffy
18Auckland District Health Board, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lise J. Estcourt
19NHS Blood and Transplant, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Fitzgerald
13Berry Consultants, Austin, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Herman Goossens
20University of Antwerp, Wilrijk, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rashan Haniffa
21University of Oxford, Bangkok, Thailand
22University College London Hospital, London, United Kingdom
23National Intensive Care Surveillance (NICST), Colombo, Sri Lanka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alisa M. Higgins
4Monash University, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas E. Hills
24Auckland City Hospital, Auckland, New Zealand
25Medical Research Institute of New Zealand (MRINZ), Wellington, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher M. Horvat
26UPMC Children’s Hospital of Pittsburgh, Pittsburgh, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francois Lamontagne
27Université de Sherbrooke, Sherbrooke, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick R. Lawler
28University Health Network, Toronto, Canada
29University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen L. Leavis
12University Medical Center Utrecht, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelsey M. Linstrum
30University of Pittsburgh, Pittsburgh, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Litton
31Fiona Stanley Hospital, Perth, Australia
32University of Western Australia, Perth, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Lorenzi
13Berry Consultants, Austin, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John C. Marshall
14St. Michael’s Hospital Unity Health, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florian B. Mayr
30University of Pittsburgh, Pittsburgh, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danny McAuley
33Queen’s University Belfast, Belfast, Northern Ireland
34Royal Victoria Hospital, Belfast, Northern Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna McGlothlin
13Berry Consultants, Austin, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shay P McGuinness
4Monash University, Melbourne, Australia
24Auckland City Hospital, Auckland, New Zealand
25Medical Research Institute of New Zealand (MRINZ), Wellington, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryan J. McVerry
30University of Pittsburgh, Pittsburgh, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie K. Montgomery
30University of Pittsburgh, Pittsburgh, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan C. Morpeth
35Middlemore Hospital, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Srinivas Murthy
36University of British Columbia, Vancouver, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katrina Orr
37Fiona Stanley Hospital, Perth, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachael L. Parke
24Auckland City Hospital, Auckland, New Zealand
38University of Auckland, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jane C. Parker
4Monash University, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asad E. Patanwala
39University of Sydney, Sydney, Australia
40Royal Prince Alfred Hospital, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ville Pettilä
41University of Helsinki and Helsinki University Hospital, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Rademaker
12University Medical Center Utrecht, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marlene S. Santos
14St. Michael’s Hospital Unity Health, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina T. Saunders
13Berry Consultants, Austin, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher W. Seymour
30University of Pittsburgh, Pittsburgh, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manu Shankar-Hari
42King’s College London, London, United Kingdom
43Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy I. Sligl
44University of Alberta, Edmonton, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexis F. Turgeon
45Université Laval, Québec City, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne M. Turner
25Medical Research Institute of New Zealand (MRINZ), Wellington, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank L. van de Veerdonk
46Radboudumc, Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan Zarychanski
47University of Manitoba, Winnipeg, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cameron Green
4Monash University, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger J. Lewis
13Berry Consultants, Austin, United States
48Harbor-UCLA Medical Center, Torrance, CA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Derek C. Angus
31Fiona Stanley Hospital, Perth, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colin J. McArthur
24Auckland City Hospital, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Berry
13Berry Consultants, Austin, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve A. Webb
4Monash University, Melbourne, Australia
49St John of God Hospital, Subiaco, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lennie P.G. Derde
12University Medical Center Utrecht, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear.

Methods We evaluated tocilizumab and sarilumab in an ongoing international, multifactorial, adaptive platform trial. Adult patients with Covid-19, within 24 hours of commencing organ support in an intensive care unit, were randomized to receive either tocilizumab (8mg/kg) or sarilumab (400mg) or standard care (control). The primary outcome was an ordinal scale combining in-hospital mortality (assigned −1) and days free of organ support to day 21. The trial uses a Bayesian statistical model with pre-defined triggers to declare superiority, efficacy, equivalence or futility.

Results Tocilizumab and sarilumab both met the pre-defined triggers for efficacy. At the time of full analysis 353 patients had been assigned to tocilizumab, 48 to sarilumab and 402 to control. Median organ support-free days were 10 (interquartile range [IQR] −1, 16), 11 (IQR 0, 16) and 0 (IQR −1, 15) for tocilizumab, sarilumab and control, respectively. Relative to control, median adjusted odds ratios were 1.64 (95% credible intervals [CrI] 1.25, 2.14) for tocilizumab and 1.76 (95%CrI 1.17, 2.91) for sarilumab, yielding >99.9% and 99.5% posterior probabilities of superiority compared with control. Hospital mortality was 28.0% (98/350) for tocilizumab, 22.2% (10/45) for sarilumab and 35.8% (142/397) for control. All secondary outcomes and analyses supported efficacy of these IL-6 receptor antagonists.

Conclusions In critically ill patients with Covid-19 receiving organ support in intensive care, treatment with the IL-6 receptor antagonists, tocilizumab and sarilumab, improved outcome, including survival. (ClinicalTrials.gov number: NCT02735707)

Competing Interest Statement

Dr. Gordon reports grants from NIHR, grants from NIHR Research Professorship (RP-2015-06-18), non-financial support from NIHR Clinical Research Network, non-financial support from Roche Products Ltd, non-financial support from Sanofi (Aventis Pharma Ltd), during the conduct of the study; personal fees from GlaxoSmithKline, personal fees from Bristol Myers Squibb, personal fees from 30 Respiratory, outside the submitted work

Clinical Trial

NCT02735707

Clinical Protocols

https://www.remapcap.org/protocol-documents

Funding Statement

The Platform for European Preparedness Against (Re-) emerging Epidemics (PREPARE) consortium by the European Union, FP7-HEALTH-2013-INNOVATION-1 (#602525), the Rapid European COVID-19 Emergency Research response (RECOVER) consortium by the European Unions Horizon 2020 research and innovation programme (#101003589), the Australian National Health and Medical Research Council (#APP1101719), the Health Research Council of New Zealand (#16/631), and the Canadian Institute of Health Research Strategy for Patient-Oriented Research Innovative Clinical Trials Program Grant (#158584), the UK National Institute for Health Research (NIHR) and the NIHR Imperial Biomedical Research Centre, the Health Research Board of Ireland (CTN 2014-012), the UPMC Learning While Doing Program, the Breast Cancer Research Foundation, the French Ministry of Health (PHRC-20-0147), the Minderoo Foundation and the Wellcome Trust Innovations Project (215522). ACG is funded by an NIHR Research Professorship (RP-2015-06-18) and MSH by an NIHR Clinician Scientist Fellowship (CS-2016-16-011). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Immune Modulation Domain protocol for tocilizumab and sarilumab was approved by the following independent ethics committees in these participating countries; UK, London Surrey Borders Research Ethics Committee; Netherlands, Medisch Ethische Toetsingscommissie Utrecht (METC Utrecht); Australia, Sydney Local District ethics Review Committee (Royal Prince Alfred Hospital); New Zealand, Northern A Health and Disability Ethics Committee; Ireland, St Vincents Healthcare Group Ethics and Medical Research Committee; Kingdom of Saudi Arabia, King Abdullah International Medical Research Center Institutional Review Board.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Author and Group Information The members of the writing committee appear below and the full list of investigators and collaborators appear in the Supplementary Appendix.

  • Affiliation of author corrected Figures 2 and 3 correctly re-labelled

Data Availability

Data will be available to researchers on request subject to sponsor restrictions from 1-10-2021. Please contact info{at}remapcap.org

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 09, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report
The REMAP-CAP Investigators, Anthony C. Gordon, Paul R. Mouncey, Farah Al-Beidh, Kathryn M. Rowan, Alistair D. Nichol, Yaseen M. Arabi, Djillali Annane, Abi Beane, Wilma van Bentum-Puijk, Lindsay R. Berry, Zahra Bhimani, Marc J.M. Bonten, Charlotte A. Bradbury, Frank M. Brunkhorst, Adrian Buzgau, Allen C. Cheng, Michelle A. Detry, Eamon J. Duffy, Lise J. Estcourt, Mark Fitzgerald, Herman Goossens, Rashan Haniffa, Alisa M. Higgins, Thomas E. Hills, Christopher M. Horvat, Francois Lamontagne, Patrick R. Lawler, Helen L. Leavis, Kelsey M. Linstrum, Edward Litton, Elizabeth Lorenzi, John C. Marshall, Florian B. Mayr, Danny McAuley, Anna McGlothlin, Shay P McGuinness, Bryan J. McVerry, Stephanie K. Montgomery, Susan C. Morpeth, Srinivas Murthy, Katrina Orr, Rachael L. Parke, Jane C. Parker, Asad E. Patanwala, Ville Pettilä, Emma Rademaker, Marlene S. Santos, Christina T. Saunders, Christopher W. Seymour, Manu Shankar-Hari, Wendy I. Sligl, Alexis F. Turgeon, Anne M. Turner, Frank L. van de Veerdonk, Ryan Zarychanski, Cameron Green, Roger J. Lewis, Derek C. Angus, Colin J. McArthur, Scott Berry, Steve A. Webb, Lennie P.G. Derde
medRxiv 2021.01.07.21249390; doi: https://doi.org/10.1101/2021.01.07.21249390
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report
The REMAP-CAP Investigators, Anthony C. Gordon, Paul R. Mouncey, Farah Al-Beidh, Kathryn M. Rowan, Alistair D. Nichol, Yaseen M. Arabi, Djillali Annane, Abi Beane, Wilma van Bentum-Puijk, Lindsay R. Berry, Zahra Bhimani, Marc J.M. Bonten, Charlotte A. Bradbury, Frank M. Brunkhorst, Adrian Buzgau, Allen C. Cheng, Michelle A. Detry, Eamon J. Duffy, Lise J. Estcourt, Mark Fitzgerald, Herman Goossens, Rashan Haniffa, Alisa M. Higgins, Thomas E. Hills, Christopher M. Horvat, Francois Lamontagne, Patrick R. Lawler, Helen L. Leavis, Kelsey M. Linstrum, Edward Litton, Elizabeth Lorenzi, John C. Marshall, Florian B. Mayr, Danny McAuley, Anna McGlothlin, Shay P McGuinness, Bryan J. McVerry, Stephanie K. Montgomery, Susan C. Morpeth, Srinivas Murthy, Katrina Orr, Rachael L. Parke, Jane C. Parker, Asad E. Patanwala, Ville Pettilä, Emma Rademaker, Marlene S. Santos, Christina T. Saunders, Christopher W. Seymour, Manu Shankar-Hari, Wendy I. Sligl, Alexis F. Turgeon, Anne M. Turner, Frank L. van de Veerdonk, Ryan Zarychanski, Cameron Green, Roger J. Lewis, Derek C. Angus, Colin J. McArthur, Scott Berry, Steve A. Webb, Lennie P.G. Derde
medRxiv 2021.01.07.21249390; doi: https://doi.org/10.1101/2021.01.07.21249390

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Intensive Care and Critical Care Medicine
Subject Areas
All Articles
  • Addiction Medicine (241)
  • Allergy and Immunology (521)
  • Anesthesia (125)
  • Cardiovascular Medicine (1425)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (585)
  • Epidemiology (10307)
  • Forensic Medicine (6)
  • Gastroenterology (528)
  • Genetic and Genomic Medicine (2637)
  • Geriatric Medicine (254)
  • Health Economics (497)
  • Health Informatics (1740)
  • Health Policy (790)
  • Health Systems and Quality Improvement (676)
  • Hematology (268)
  • HIV/AIDS (568)
  • Infectious Diseases (except HIV/AIDS) (12103)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2466)
  • Nursing (145)
  • Nutrition (379)
  • Obstetrics and Gynecology (493)
  • Occupational and Environmental Health (568)
  • Oncology (1327)
  • Ophthalmology (403)
  • Orthopedics (147)
  • Otolaryngology (238)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (343)
  • Pediatrics (784)
  • Pharmacology and Therapeutics (330)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2405)
  • Public and Global Health (5018)
  • Radiology and Imaging (895)
  • Rehabilitation Medicine and Physical Therapy (530)
  • Respiratory Medicine (682)
  • Rheumatology (309)
  • Sexual and Reproductive Health (256)
  • Sports Medicine (246)
  • Surgery (298)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)